Clinical trials
Type 1 diabetes clinical trials
An autoimmune condition where the body makes little or no insulin. We’re tracking 875 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07351318Enrolling by invitation
Insulin sensitivity in type 1 diabetes pregnancies
This study looks at how well the body uses insulin in women who had type 1 diabetes during a recent pregnancy. If you used a Dexcom CGM and Tandem insulin pump while pregnant, your data could help researchers better understand insulin needs in pregnancy.
Chicago, IllinoisAges 18 years+ - NCT07289204Enrolling by invitation
How Aging Affects People with Type 1 Diabetes
This trial looks at how aging affects people with type 1 diabetes. It is for older adults who are already in a major Finnish diabetes study to help understand health changes over time.
HelsinkiAges 65 years+ - NCT07239700Enrolling by invitation
Buzzy and TickleFlex for easier insulin shots in kids
This study tests two devices, Buzzy and TickleFlex, to see if they can reduce pain and fear during insulin injections in children with type 1 diabetes. It may help make daily injections more comfortable.
Hakkari, CentreAges 6–12 - NCT07164768Enrolling by invitation
Thinking and mood in kids with type 1 diabetes
This study looks at how type 1 diabetes affects thinking skills and emotional health in children, teens, and young adults. Both the young person and one of their parents will answer questions together.
Pune, MaharashtraAges 10–21 - NCT07122180Enrolling by invitation
14-day study of a new continuous glucose monitor for diabetes
This study tests a new continuous glucose monitor (CGM) that you wear for 14 days. It checks how accurate the device is and how well it helps track your blood sugar levels, all while being safe and easy to use.
Riga, RigaAges 18–80 - NCT07107789Enrolling by invitation
Can animated videos help kids with type 1 diabetes?
This study tests whether watching short education videos with animations can help children with type 1 diabetes better manage their blood sugar, take care of themselves, and feel more positive about their condition. It's for kids aged 11 to 18 who use an insulin pen.
Erzurum, PalandökenAges 11–18 - NCT07037810Enrolling by invitation
Comparing two ways to match insulin to meals in type 1 diabetes
This study tests two methods for deciding how much insulin to take with meals: counting exact carbohydrates or using a simpler meal-size guide. It aims to see which approach works best for people with type 1 diabetes who already use multiple daily injections and have moderate to high blood sugar levels (HbA1c 7.5% to under 11%).
Kuwait CityAges 21 years+ - NCT06906653Enrolling by invitation
Proactive care for newly diagnosed type 2 diabetes
This trial tests a new, proactive approach to help people newly diagnosed with type 2 diabetes manage their condition through better initial care and support. If you’re a Kaiser Permanente Northern California member, you may get extra resources and guidance right from the start.
Pleasanton, CaliforniaAges 18–74 - NCT06904846Enrolling by invitation
Testing a new continuous glucose monitor for 60 days
This study tests a new continuous glucose monitor (CGM) called iCan o3 that you wear on your abdomen for 60 days. It helps track your blood sugar levels continuously, so you and your doctor can see patterns and make better decisions about your diabetes care.
AntwerpAges 18–75 - NCT06821360Enrolling by invitation
Confirming type 1 diabetes remotely
This study checks if type 1 diabetes can be confirmed through a remote process rather than in-person visits. It may help make follow-up care easier for people with type 1 diabetes.
Exeter, DevonAges 18 years+ - NCT06786546Enrolling by invitation
Type 1 Diabetes and Blood Vessel Health Study
This study looks at how blood vessels and nerves work in people with Type 1 diabetes compared to healthy volunteers. It may help explain how diabetes affects heart and blood vessel health.
Austin, TexasAges 18–70 - NCT06730906Enrolling by invitation
PACTAID app for managing exercise in type 1 diabetes
This study tests an app called PACTAID that helps adults with type 1 diabetes manage their blood sugar during exercise. You will try three different types of workouts to see how well the app works.
Rochester, MinnesotaAges 18–65 - NCT06676566Enrolling by invitation
Follow-up and early detection for kids at risk of type 1 diabetes
This study follows children who are at genetic risk for type 1 diabetes or have early immune signs (autoantibodies) but do not yet need insulin. It provides extra checkups and information to catch the disease early and help families understand their child's risk.
MalmöAges birth–18 years - NCT06598345Enrolling by invitation
Pet fish care for better diabetes management in teens
This study tests if taking care of a pet fish can help kids aged 10-13 with type 1 diabetes improve their blood sugar control and take more responsibility for their diabetes care.
Durham, North CarolinaAges 10–13 - NCT06420661Enrolling by invitation
School program for children with type 1 diabetes
This study tests a special program called SPACE that helps children with type 1 diabetes by working together with their school nurse and diabetes team. The goal is to improve diabetes care and support at school.
Pittsburgh, PennsylvaniaAges 5–12 - NCT06300047Enrolling by invitation
Diabetes transition support for young adults
This study tests a transition coordinator to help teens with type 1 diabetes move from pediatric to adult care. It aims to make the process smoother and improve health outcomes.
Calgary, AlbertaAges 17–18 - NCT06154135Enrolling by invitation
Test of DBLG1 closed-loop insulin delivery for type 1 diabetes
This study tests how well a new closed-loop insulin delivery system (DBLG1) helps manage blood sugar and improves quality of life for adults with type 1 diabetes. If you are starting this system, the study will track your glucose control and ask about your daily experiences.
AalstAges 18 years+ - NCT06113588Enrolling by invitation
Moving from pediatric to adult diabetes care
This trial looks at how teenagers and young adults with type 1 diabetes move from pediatric to adult diabetes care. The goal is to learn how to make this transition smoother and better support patients and their families.
Sydney, New South WalesAges 16 years+ - NCT05055804Enrolling by invitation
Study links an ELG test reading to blood glucose
This study looks at whether a new ELG test reading matches your blood sugar results in people with type 1 or type 2 diabetes. You may be asked to fast and come for two short visits so researchers can compare the tests.
Springdale, ArkansasAges 25–65 - NCT04677699Enrolling by invitation
Testing blood for signs of celiac disease and diabetes
This study screens children’s blood to look for signs of celiac disease and type 1 diabetes. It may help doctors understand who is developing these conditions early.
Seattle, WashingtonAges 1 day–7 years - NCT03585153Enrolling by invitation
Pancreas imaging study in people with type 1 diabetes
This study takes pictures of the pancreas in children and teens (and likely adults) with type 1 diabetes soon after diagnosis. The goal is to learn more about how the pancreas changes with diabetes, which may help future care.
Aurora, ColoradoAges 8 years+ - NCT05816343RecruitingPhase 2
Orlistat for high triglycerides in people with rare genetic lipid conditions
This Phase 2 trial studies how well and how safely orlistat works over the long term for people who have very high triglycerides linked to rare genetic lipid disorders. It may help lower triglycerides and assess long-term side effects, but you must meet specific genetic, lab, and health requirements.
Dallas, TexasAges 8 years+ - NCT07054125Recruiting
CGM, education, and peer support for type 2 diabetes
This trial tests if using a continuous glucose monitor (a small sensor that tracks your blood sugar), combined with diabetes education and support from others with diabetes, can help people with type 2 diabetes better control their blood sugar. You may qualify if your blood sugar is not well controlled (A1c above 8%).
Asheville, North CarolinaAges 18 years+ - NCT07319286Enrolling by invitationPhase 1/Phase 2
GLP-1 drug for period problems in teens with type 1 diabetes
This trial tests whether a GLP-1 receptor agonist can help improve irregular periods in teenage girls with type 1 diabetes. It's for girls aged 12 to 18 who have had their period for at least 2 years, use a continuous glucose monitor, and have higher blood sugar levels (HbA1c of 7% or more).
Cairo, Cairo GovernorateAges 12–18
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 1 diabetes?
- Yes. Clin2 currently lists 875 recruiting type 1 diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 1 diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 1 diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.